A Conversation with Professor Josué Sznitman
Join us for a discussion with one of the Technion’s brightest rising researchers, a prime example of how the Technion’s interdisciplinary work addresses critical challenges in human health. Learn the fascinating story of how he created a technology that could counter some of the most dreaded symptoms of COVID-19 and enjoy connecting with fellow supporters in our community.
By now we are all too familiar with the shortness of breath, rapid breathing, and low blood oxygen levels that often land patients with coronavirus in intensive care. Acute Respiratory Distress Syndrome (ARDS) remains the leading cause of death in COVID-19 patients. Prof. Josué Sznitman will speak about his Liquid Foam Therapy (LIFT), an innovative technology to deliver drugs to the lungs, and current progress in their preclinical research with surfactant delivery to address ARDS in severe COVID-19 patients.
This virtual event will be hosted by Michael and Nolan Greenwald. Mrs. Greenwald is an Associate at Targeted Victory, a digital strategy firm, working with political clientele. Mr. Greenwald, who will moderate the discussion, is Director at Tiedemann Advisors, an investment management firm. Mr. Greenwald has held senior diplomatic positions in the U.S. Treasury, and is a frequent speaker and writer on international security, the Middle East, and the global economy. He is active in the ATS in Palm Beach and New York City.
ABOUT THE SPEAKERS
Associate Professor Josué Sznitman heads the Technion Biofluids Laboratory in the Faculty of Biomedical Engineering and is also the director of the Norman Seiden Multidisciplinary Graduate Program in Nanoscience and Nanotechnology in the Russell Berrie Nanotechnology Institute. He is fast becoming a world leader in pulmonary physiology and drug delivery to the lungs. Sznitman was awarded the Young Investigator Award (2015) by the International Society of Aerosols in Medicine (ISAM) and the 2018 Emerging Scientist Award in Drug Delivery to the Lungs.